Medibio Ltd
ASX:MEB

Watchlist Manager
Medibio Ltd Logo
Medibio Ltd
ASX:MEB
Watchlist
Price: 0.02 AUD Market Closed
Market Cap: 122m AUD
Have any thoughts about
Medibio Ltd?
Write Note

Wall Street
Price Targets

MEB Price Targets Summary
Medibio Ltd

There are no price targets for MEB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Medibio Ltd Competitors:
Price Targets
300451
B-SOFT Co Ltd
26% Upside
2192
Medlive Technology Co Ltd
13% Upside
PHR
Phreesia Inc
23% Upside
PHF
Pharmagest Interactive SA
60% Upside
2150
CareNet Inc
57% Upside
688246
Goodwill E-Health Info Co Ltd
46% Upside
TDOC
Teladoc Health Inc
22% Upside
HSTM
HealthStream Inc
5% Upside

Revenue
Forecast

Revenue Estimate
Medibio Ltd

For the last 8 years the compound annual growth rate for Medibio Ltd's revenue is 18%. The projected CAGR for the next 5 years is 33%.

18%
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Medibio Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Medibio Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEB's stock price target?
Not Available

MEB doesn't have any price targets made by Wall Street professionals.

What is Medibio Ltd's Revenue forecast?
Projected CAGR
33%

For the last 8 years the compound annual growth rate for Medibio Ltd's revenue is 18%. The projected CAGR for the next 5 years is 33%.

Back to Top